Connection

Nivedita Gupta to Vaccination

Back to Details
This is a "connection" page, showing publications Nivedita Gupta has written about Vaccination.
Nivedita Gupta
Connection Strength
0.026
Vaccination
  1. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961.
    View in: PubMed
    Score: 0.009
  2. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
    View in: PubMed
    Score: 0.009
  3. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine. 2018 12 18; 36(52):7909-7912.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.